Neonatal Hearing Screening Associated with Congenital Syphilis and HIV

Luciele Kauana Woide1, Carolina Schmitz Tiezerin2, Luciana Berwanger Cigana3

  • 1Student of the Undergraduate Course in Speech Therapy, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC Brazil.

Insights

Universal Neonatal Hearing Screening (UNHS) effectively identifies hearing loss in newborns. Retesting is crucial for monitoring hearing health, especially when congenital syphilis and HIV are present, ensuring better neonatal outcomes.

Area of Science:

  • Neonatal Health
  • Public Health
  • Audiology

Background:

  • Hearing is vital for newborn development.
  • Universal Neonatal Hearing Screening (UNHS) aims for early detection of hearing loss.
  • Congenital syphilis and HIV are linked to neonatal hearing loss, yet underreporting is a concern.

Purpose of the Study:

  • To determine the prevalence of congenital syphilis and HIV in newborns in Greater Florianópolis.
  • To evaluate the impact of these infections on hearing outcomes through UNHS retests.
  • To analyze UNHS retest data from 2018 to 2022.

Main Methods:

  • Retrospective cross-sectional study utilizing secondary data.
  • Inclusion of newborns referred for Otoacoustic Emissions (OAE) and Brainstem Auditory Evoked Potential (BAEP) retests.
  • Data collected from a SUS Hearing Health Care Service (SASA) between 2018 and 2022.

Main Results:

  • Out of 1211 newborns referred for retesting, 283 had investigated infections.
  • Congenital syphilis affected 170 (59.86%), HIV affected 105 (36.67%), and 8 (2.82%) had both.
  • One newborn failed the retest; others passed, indicating screening effectiveness.

Conclusions:

  • UNHS is an effective screening tool for neonatal hearing loss.
  • Retesting is essential for accurate hearing health monitoring in newborns.
  • The study supports public health guidelines for neonatal and hearing health screening.